PDGFRB and neoplasm: Experiments using the hypomorphic PDGFB-ret/ret mouse model, which expresses a truncated form of PDGF-B, lacking the C-terminal retention motif, resulted in impaired tumor angiogenesis and reduced pericyte coverage implying PDGF-BB/PDGFRβ as a promising, potential therapeutical target [70].